⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGNX News
REGENXBIO Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of REGENXBIO Inc. - RGNX
accessnewswire.com
RGNX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of REGENXBIO Inc. - RGNX
prnewswire.com
RGNX
Investigation into Regenxbio: Questions Arise Over Disclosure Completeness Prior to FDA Action
prnewswire.com
RGNX
RGNX ALERT: Levi & Korsinsky Investigates REGENXBIO Inc. for Possible Securities Fraud Violations Ready to Announce with Confidence?
newsfilecorp.com
RGNX
INVESTOR ALERT: Investigation of REGENXBIO Inc. (RGNX) by Holzer & Holzer, LLC
globenewswire.com
RGNX
REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs
prnewswire.com
RGNX
Catalyst Monitor Report: Q1 2026 Outlook: Regulatory Approvals and Late-Stage Trials Signal Strong Pipeline Momentum Across Key Therapeutic Areas
globenewswire.com
GSK
RGNX
OMER
XENE
NMRA
Muscular Dystrophy Association’s Legacy Awards Honor Innovators in Clinical and Scientific Research, and Community Impact at the 2026 MDA Clinical & Scientific Conference in March
globenewswire.com
ARGX
BIIB
BBIO
NVS
RGNX
SCHR
REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
prnewswire.com
RGNX
CoEffex Launches to Redefine Leadership Development with Data-Driven Coaching for High Growth Companies
prnewswire.com
GNK
NVS
RGNX